BMI modifies HDL-C effects on coronary artery bypass grafting outcomes

Abstract

Background Despite the recognized implications of high-density lipoprotein cholesterol (HDL-C) in cardiovascular diseases, the role of body mass index (BMI) in HDL-C association with cardiovascular outcomes remains unclear. This study investigated the possible modifying implications of BMI on the correlation between HDL-C and coronary artery bypass grafting (CABG) outcomes. Methods The present cohort included isolated CABG patients (median follow-up: 76.58 [75.79–77.38] months). The participants were classified into three groups: 18.5 ≤ BMI < 25 (normal), 25 ≤ BMI < 30 (overweight), and 30 ≤ BMI < 35 (obese) kg/m2. Cox proportional hazard models (CPHs) and restricted cubic splines (RCSs) were applied to evaluate the relationship between HDL-C and all-cause mortality as well as major adverse cardio-cerebrovascular events (MACCEs) in different BMI categories. Results This study enrolled a total of 15,639 patients. Considering the final Cox analysis among the normal and overweight groups, HDL-C ≥ 60 was a significant protective factor compared to 40 < HDL-C < 60 for all-cause mortality (adjusted hazard ratio (aHR): 0.47, P: 0.027; and aHR: 0.64, P: 0.007, respectively). However, the protective effect of HDL-C ≥ 60 was no longer observed among patients with 30 ≤ BMI < 35 (aHR: 1.16, P = 0.668). RCS trend analyses recapitulated these findings; among 30 ≤ BMI < 35, no uniform inverse linear association was observed; after approximately HDL-C≈55, its increase was no longer associated with reduced mortality risk. RCS analyses on MACCE revealed a plateau effect followed by a modest rise in overweight and obese patients from HDL-C = 40 onward (nonlinear association). Conclusions Very high HDL-C (≥ 60 mg/dL) was not related to better outcomes among obese CABG patients. Furthermore, HDL-C was related to the post-CABG outcomes in a nonlinear manner, and the magnitude of its effects also differed across BMI subgroups.

The prognostic role of the low and very low baseline LDL-C level in outcomes of patients with cardiac revascularization; comparative registry-based cohort design

“…A second explanation may be that patients with higher cholesterol concentrations are more likely to be taking medications such as β-blockers and angiotensin-converting enzyme inhibitors before their admission; as a result, these medications may individually or synergistically contribute to the paradoxically lower risk of patients with 70 mg/dl < LDL-C ≤ 100 mg/dl as compared to patients with LDL-C < 70 mg/dl. A third explanation may be that in patients with very low serum LDL-C levels, HDL-C levels are also comparatively lower, which may be prognostically more impactful than the former [ 32 ]. Accordingly, Ogita et al revealed that, despite achieving optimal LDL-C control after coronary revascularization, diabetic patients with low serum HDL-C levels had higher rates of major cardiovascular events [ 33 ].…”

Identification of subgroups within a Japanese older adult population for whom statin therapy is effective in reducing mortality

“…protective cardiovascular effects of HDL-cholesterol may be attenuated in individuals with higher BMI [39]. This raises an intriguing question concerning the potential modulation of statin efficacy in the context of elevated BMI.…”

Evaluating the pure effect of weight on cardiac function in patients with cardiac syndrome X

“…Obesity is a complex, multifactorial, and largely preventable disease, affecting up to a third of the world's population in the recent decades. [1][2][3] Obesity is a major risk factor for cardiovascular complications and heart failure by predisposing to hypertension, dyslipidemia, diabetes mellitus, coronary artery disease, and sleep apnea syndrome. [4][5][6][7][8][9][10] Several mechanisms are involved in the pathogenesis of left ventricle (LV) dysfunction in obese individuals.…”